Protective effects of silymarin on fumonisin B1-induced hepatotoxicity in mice

Journal of Veterinary Science

Volumn 15, Issue 1, 2014, Pages 51-60

  Sozmen, Mahmut ^a   Devrim, Alparslan Kadir ^b   Tunca, Recai ^c   Bayezit, Murat ^b   Dag, Serpil ^d   Essiz, Dinc ^e  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b MEHMET AKIF ERSOY UNIVERSITY   (Turkey)

^c ADNAN MENDERES UNIVERSITY   (Turkey)

^d KAFKAS UNIVERSITY   (Turkey)

^e KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Caspase 8; Fibroblast growth factor 2; Fumonisin B1; Galectin 3; Silymarin

Indexed keywords

ANTIOXIDANT; CYCLINE; FIBROBLAST GROWTH FACTOR 2; FUMONISIN; FUMONISIN B1; KI 67 ANTIGEN; MYCOTOXIN; SILYMARIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LIVER; LIVER CELL; METABOLISM; MOUSE; TOXICITY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL PROLIFERATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; FUMONISINS; GENE EXPRESSION REGULATION; HEPATOCYTES; KI-67 ANTIGEN; LIVER; MICE; MICE, INBRED BALB C; MYCOTOXINS; NEOVASCULARIZATION, PHYSIOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; SILYMARIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84896373652     PISSN: 1229845X     EISSN: 1976555X     Source Type: Journal    
DOI: 10.4142/jvs.2014.15.1.51     Document Type: Article

References (30)

1. Ankoma-Sey V, Matli M, Chang KB, Lalazar A, Donner DB, Wong L, Warren RS, Friedman SL. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 1998, 17, 115-121.
2. Basilico C, Moscatelli D. The FGF family of growth factors and oncogenes. Adv Cancer Res 1992, 59, 115-165.
3. Bhandari N, He Q, Sharma RP. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice. Toxicology 2001, 165, 195-204.
4. Bhandari N, Sharma RP. Fumonisin B1-induced alterations in cytokine expression and apoptosis signaling genes in mouse liver and kidney after an acute exposure. Toxicology 2002, 172, 81-92.
5. Bhandari N, Sharma RP. Modulation of selected cell signaling genes in mouse liver by fumonisin B1. Chem Biol Interact 2002, 139, 317-331.
6. Ciacci-Zanella JR, Jones C. Fumonisin B1, a mycotoxin contaminant of cereal grains and inducer of apoptosis via the tumor necrosis factor pathway and caspase activation. Food Chem Toxicol 1999, 37, 703-712.
7. Donahower B, Mc Cullough SS, Kurten R, Lamps LW, Simpson P, Hinson JA, James LP. Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am J Physiol Gastrointest Liver Physiol 2006, 291, G102-109.
8. Dragan YP, Bidlack WR, Cohen SM, Goldsworthy TL, Hard GC, Howard PC, Riley RT, Voss KA. Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B1 as an example. Toxicol Sci 2001, 61, 6-17.
9. Dugyala RR, Sharma RP, Tsunoda M, Riley RT. Tumor necrosis factor-á as a contributor in fumonisin B1-toxicity. J Pharmacol Exp Ther 1998, 285, 317-324.
10. He Q, Kim J, Sharma RP. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases. Toxicol Sci 2004, 80, 335-342.
11. Hsu DK, Dowling CA, Jeng KCG, Chen JT, Yang RY, Liu FT. Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma. Int J Cancer 1999, 81, 519-526.
12. Hsu YC, Chiu YT, Lee CY, Wu CF, Huang YT. Anti-fibrotic effects of tetrandrine on bile-duct ligated rats. Can J Physiol Pharmacol 2006, 84, 967-976.
13. Ishikawa K, Mochida S, Mashiba S, Inao M, Matsui A, Ikeda H, Ohno A, Shibuya M, Fujiwara K. Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. Biochem Biophys Res Commun 1999, 254, 587-593.
14. Kim H, Lee J, Hyun JW, Park JW, Joo H, Shin T. Expression and immunohistochemical localization of galectin-3 in various mouse tissues. Cell Biol Int 2007, 31, 655-662.
15. Li LH, Wu LJ, Tashiro S, Onodera S, Uchiumi F, Ikejima T. Silibinin prevents UV-induced HaCaT cell apoptosis partly through inhibition of caspase-8 pathway. Biol Pharm Bull 2006, 29, 1096-1101.
16. Lim CW, Parker HM, Vesonder RF, Haschek WM. Intravenous fumonisin B1 induces cell proliferation and apoptosis in the rat. Nat Toxins 1996, 4, 34-41.
17. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002, 1572, 263-273.
18. Merrill AH Jr., Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, Wang E. Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 1997, 142, 208-225.
19. Rastogi R, Srivastava AK, Srivastava M, Rastogi AK. Hepatocurative effect of picroliv and silymarin against aflatoxin B1 induced hepatotoxicity in rats. Planta Med 2000, 66, 709-713.
20. Rosmorduc O, Wendum D, Corpechot C, Galy B, Sebbagh N, Raleigh J, Housset C, Poupon R. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 1999, 155, 1065-1073.
21. Schümann J, Prockl J, Kiemer AK, Vollmar AM, Bang R, Tiegs G. Silibinin protects mice from T cell-dependent liver injury. J Hepatol 2003, 39, 333-340.
22. Shimonishi T, Miyazaki K, Kono N, Sabit H, Tuneyama K, Harada K, Hirabayashi J, Kasai K, Nakanuma Y. Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma. Hum Pathol 2001, 32, 302-310.
23. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359, 843-845.
24. Taniguchi E, Sakisaka S, Matsuo K, Tanikawa K, Sata M. Expression and role of vascular endothelial growth factor in liver regeneration after partial hepatectomy in rats. J Histochem Cytochem 2001, 49, 121-129.
25. Tsuchihashi S, Ke B, Kaldas F, Flynn E, Busuttil RW, Briscoe DM, Kupiec-Weglinski JW. Vascular endothelial growth factor antagonist modulates leukocyte trafficking and protects mouse livers against ischemia/reperfusion injury. Am J Pathol 2006, 168, 695-705.
26. Voss KA, Riley RT, Bacon CW, Chamberlain WJ, Norred WP. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice. Nat Toxins 1996, 4, 16-23.
27. WHO IPCS. Fumonisin B1. Environmental Health Criteria 219. pp. 1-150, World Health Organization, Geneva, 2000.
28. Yamazaki K, Kawai A, Kawaguchi M, Hibino Y, Li F, Sasahara M, Tsukada K, Hiraga K. Simultaneous induction of galectin-3 phosphorylated on tyrosine residue, p21WAF1/Cip1/Sdi1, and the proliferating cell nuclear antigen at a distinctive period of repair of hepatocytes injured by CCl4. Biochem Biophys Res Commun 2001, 280, 1077-1084.
29. Yang SH, Lin JK, Huang CJ, Chen WS, Li SY, Chiu JH. Silibinin inhibits angiogenesis via Flt-1, but not KDR, receptor up-regulation. J Surg Res 2005, 128, 140-146.
30. Zi X, Mukhtar H, Agarwal R. Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of m RNA expression of an endogenous tumor promoter TNFa. Biochem Biophys Res Commun 1997, 239, 334-339.